Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148030 · ClinicalTrials.gov registry record
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
A clinical trial, sponsored by 3M.
- Terminated
- Registry status
- 333
- Enrollment target
NCT01148030: Clinical Trial study, sponsored by 3M.
NCT01148030 is a clinical trial that was terminated before completion, run by 3M. The registered enrollment target is 333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01148030 was terminated before completion, sponsored by 3M.
- TERMINATED
- Registry status
- 333 participants
- Enrollment target
Study Summary
Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.
Interventions
- DRUG 3M Skin and Nasal Antiseptic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-07 |
Why NCT01148030 stopped before completion
NCT01148030 is an observational study that tracks outcomes without assigning an intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 3M Skin and Nasal Antiseptic is the first listed.
NCT01148030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01148030 about?
NCT01148030 is a clinical study titled "Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change". Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microo...
What is the current status of trial NCT01148030?
This trial is currently terminated. The enrollment target is 333 participants. The study started on 2010-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01148030?
The interventions under investigation include: 3M Skin and Nasal Antiseptic (DRUG).
Who is sponsoring clinical trial NCT01148030?
This trial is sponsored by 3M, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07395687 · 333 participants · Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia